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1. Introduction 
Orbital myositis is an inflammation of mainly the extraocular muscles. Orbital myositis has 
a sudden onset, and the clinical course can be acute or chronic. The ocular signs and 
symptoms of eyes with orbital myositis are periocular pain, eyelid swelling and redness, 
restricted ocular motility, and strabismus. Computed tomographic (CT) scans show 
indistinct swelling around one or more extraocular muscles, and fat-suppressed T2-
weighted magnetic resonance (MR) images show localized inflammations. The exact 
etiology of the inflammation has not been determined, however some cases have been 
reported to be caused by infectious agents while other cases by autoimmunity. Spirochetotic 
(Lyme disease), viral (herpes zoster virus), and bacterial infections (Group A streptococcal 
pharyngitis) can cause orbital myositis. Autoimmune-related orbital myositis is associated 
with relatively specific diseases: giant cell myocarditis, Crohn disease, and linear 
scleroderma.   
Orbital myositis must be differentiated from other diseases that also have extraocular 
muscular enlargements, e.g., thyroid-associated orbitopathy, lymphoproliferative disorders, 
metastatic orbital diseases, parasitic infection, systemic anti-neutrophil cytoplasmic 
antibody-related vasculitis, and inflammatory conditions triggered by medications and 
foreign bodies.   
The first line of treatment of orbital myositis is systemic corticosteroids to which the 
inflammation responds well especially the acute type. However, there are corticosteroid-
resistant chronic types, and immunosuppressive and biological agents can be used in these 
types.   
2. Patients, signs and symptoms, and imaging studies 
2.1 Patients 
The etiology of orbital myositis has not been completely established. In some cases, the 
orbital myositis has a specific etiology, which is described in Section 3. Although idiopathic 
orbital myositis may occur at any age, it is most commonly present in middle-aged patients. 
Meta-analysis, including the largest published series (Siatkowski et al., 1994), showed that 
orbital myositis occured most frequently in young to middle-aged patients with a 1 male to 
2 female patient ratio (Table 1; Scott & Siatkowski, 1997). However, a relatively large 
published case series (Lacey et al., 1999) and our study did not reveal a female 
predominance (Table 1). 
It has also been reported that idiopathic orbital myositis can develop in pediatric patients. 
Pediatric cases of orbital myositis develop secondary to systemic conditions, e.g., 
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streptococcal pharyngitis (Alshaikh et al., 2008; Belanger et al., 2010) and presumed allergic 
responses (Yan et al., 2006). There are cases of orbital myositis that develop after pregnancy 
(Hiraga et al., 2008; Mombaerts & Koornneef, 1997) and cases with a familial history (Jacob 
et al., 2007; Maurer & Zierz, 1999). However, these may be exceptional cases.  
 
References Patient 
number 
Male/female 
ratio 
Median or mean age 
(range) 
Scott et al. 1997  190  0.5 37 (3-84) years old 
Lacey et al. 1999 40 0.74 40 (not available) years old 
Our study 43 1.0 47 (23-91) years old 
Table 1. Epidemiology of patients with idiopathic orbital myositis. 
2.2 Signs and symptoms 
Idiopathic orbital myositis is characterized by a sudden onset of orbital inflammation, 
periocular pain, swelling and redness of the eyelids, proptosis, ptosis, and ocular motility 
restrictions (Figure 1 to 7). It must be differentiated from idiopathic orbital inflammation 
and orbital cellulitis, because the signs and symptoms are similar. However, idiopathic 
orbital myositis can sometimes have atypical signs and symptoms, viz., subacute/chronic 
onset or be a non-inflammatory condition. These cases with atypical signs and symptoms 
simulate orbital tumors, and they account for 7% of all cases (Rootman, 2003).   
Idiopathic orbital myositis must also be differentiated from other diseases that have 
enlargements of the extraocular muscles as described in Sections 4.3 to 4.10. 
Idiopathic orbital myositis can affect any extraocular muscles but rarely the superior and 
inferior oblique muscles (Figure 7; Kau et al., 2006; Stidham et al., 1998).  It also rarely affects 
the levator palpebrae muscle (Figure 1; Almekhlafi & Fletcher. 2008). Ocular motility is 
typically restricted in the field of action of the affected extraocular muscles, and also in the 
direction opposite to its field of action (Figure 5; Kubota & Kano. 2007; Lacey et al., 1999; 
Siatkowski et al., 1994). 
Idiopathic orbital myositis can have an acute or chronic/recurrent clinical course. Acute 
orbital myositis is generally resolved within 2 months after systemic steroid therapy (Figure 
5 and 6). However, chronic/recurrent orbital myositis responds poorly to systemic steroid 
therapy, and the ocular motility is restricted for more than 2 months and often years  
(Figure 7).   
 
 
Fig. 1. Idiopathic orbital myositis of left levator palpebrae muscle.   
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External photograph of an 82-year-old man showing left ptosis but with normal ocular 
motility. Fat-suppressed T2-weighted MR image shows a hyperintense signal in the left 
levator palpebrae muscle (arrowhead). He recovered spontaneously. 
 
 
Fig. 2. External photographs of patients with idiopathic orbital myositis. Left. A 91-year-old 
woman showing unilateral chemosis and ptosis, and with ocular motility restrictions.  
Right. A 26-year-old man with ptosis, ocular motility restrictions, and periocular pain. 
 
 
Fig. 3. External photographs of a patient with idiopathic orbital myositis. Left: A 32-year-old 
woman showing left upper eyelid swelling and redness. Right: Same patient after a bilateral 
recurrence while being treated with 5 mg maintenance dose of prednisolone and one week 
after 1000 mg intravenous methylprednisolone for 3 days. 
2.3 Imaging studies 
CT scans of eyes with idiopathic orbital myositis show indistinct swelling around one or 
more muscles with no specific pattern of which muscle is enlarged (Figure 2 to 6). On the 
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other hand, the MR images of acute and chronic/recurrent type of orbital myositis have 
characteristic patterns. Fat-suppressed T2-weighted MR images showed inflammation of the 
extraocular muscles rather than the ocular adnexal structures (Ohnishi et al., 1994). 
Localized inflammation of the extraocular muscles in eyes with idiopathic orbital myositis at 
the active stage can be seen in Figures 4 to 7. The acute type of idiopathic orbital myositis 
has localized areas of hyperintense signals around the extraocular muscles and fascicle 
structures, whereas the chronic/recurrent type shows areas of hyperintense signals in the 
extraocular muscles (Kubota & Kano, 2007).   
 
 
 
Fig. 4. Fat-suppressed T2-weighted MR image and coronal (middle) and axial (right) CT 
images recorded at the same time in a patient with idiopathic orbital myositis in the active 
phase. Top: Acute type of idiopathic orbital myositis. Fat-suppressed T2-weighted MR 
image shows a hyperintense signal in the fascicle structure (arrowhead) around the superior 
rectus muscle, and indistinct swelling around the superior rectus muscle in the CT image 
(Top center). An arrow points to the optic nerve for comparison to coronal CT scan at the 
posterior pole. Bottom: Chronic type of idiopathic orbital myositis. Fat-suppressed T2-
weighted MR image shows a hyperintense signal of the superior rectus muscle (arrow) and 
the adjacent structures (arrowhead). Reproduced with permission from Kubota, T. & Kano, 
H. (2007) Assessment of inflammation in idiopathic orbital myositis with fat-suppressed T2-
weighted magnetic resonance imaging. American Journal of Ophthalmology, Vol.143, No. 4, 
pp.718-720, ISSN:0002-9394  
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Fig. 5. Acute type of idiopathic orbital myositis. Left: External photographs of a 58-year-old 
man showing swelling of the right eyelid, ptosis, and ocular motility restrictions in the field 
of action and in the direction opposite to the field of action of the affected extraocular 
muscles. Severe engorgement of the conjunctival and episcleral vessels overlying the right 
eye. Fat-suppressed T2-weighted MR image at the active phase shows a hyperintense signal 
around the fascicular structures (arrowhead). Right: Same patient after 1000 mg intravenous 
methylprednisolone for 3 days (steroid pulse therapy). There is a complete recovery from 
signs and symptoms. MR images are normal. 
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Fig. 6. Acute type of atypical idiopathic orbital myositis. Left: External photographs of a 65-
year-old woman showing the left blepharoptosis, and also with ocular motility restrictions 
in the field of action of the affected extraocular muscles. Signs including subacute onset and 
non-inflammatory conditions indicate that this is atypical idiopathic orbital myositis. Right: 
CT images shows indistinct swelling around the superior rectus muscle of the left eye. Fat-
suppressed T2-weighted MR image shows hyperintense signal around the fascicular 
structures (arrowhead). Following steroid pulse therapy, she completely recovered from the 
signs and symptoms. 
3. Etiological factors 
The cause of the orbital myositis is not known in most cases, however several cases with 
known etiology have been reported. Infectious and autoimmune-related factors that affect 
the extraocular muscles are described in this section. 
3.1 Infectious agents causing orbital myositis 
Cases of orbital myositis caused by infectious agents are rare. Spirochetes (Lyme disease), 
viruses (herpes zoster virus), and bacteria (Group A streptococcal pharyngitis) are microbes 
that can cause infectious orbital myositis. The signs and symptoms of each infectious agent 
are similar to those of idiopathic orbital myositis; acute onset, periocular inflammation, 
periocular pain, conjunctival hyperemia, eyelid swelling, diplopia, and restriction of ocular 
movements. Imaging studies show that the findings in eyes caused by the different 
infectious agent are also similar to those of idiopathic orbital myositis. The protocol of 
treatment depends on the sensitivity profile of each microbe.  
Lyme disease is caused by the spirochete Borrelia burgdorferi and is mainly reported in the 
northern and western United States and also in Europe. Ticks transmit the spirochete which 
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Fig. 7. Cronic/recurrent type of ipathic orbital myositis. A 46-year-old woman with left 
periocular inflammation and ocular motility restrictions was referred to our hospital 
because her myositis was refractory to high doses of prednisolone with a slow taper. A: Fat-
suppressed T2-weighted MR image at the initial examination shows hyperintense signals in 
the left inferior and lateral rectus, and superior oblique muscles. B: Following steroid pulse 
therapy, there is a complete recovery of the signs and symptoms. C: and D: and E: She 
received high dose steroid (prednisolone 60mg) with a slow taper, however the myositis 
recurred three times during the tapering.  Note that more than one muscle including the 
right superior oblique muscle was affected. F: She developed a strabisumus two years after 
the initial visit and had persistent ocular motility restrictions.  
can affect different organ: the skin, nervous system, heart, joints, and muscles (Holmgren & 
Matteson, 2006; Muller-Felber et al., 1993; Pendse et al., 2006). The infection by Borrelia 
burgdorferi can be unilateral and more than one extraocular muscle can be infected. Lyme 
disease also has other ocular manifestations, dacroadenitis (Nieto et al., 2008), periocular 
inflammation (Carvounis et al., 2004; Holak et al., 2006), and neuro-ophthalmologic 
manifestations (Lesser et al., 1990; Pendse et al., 2006; Seidenberg et al., 1990). The diagnosis 
is based on the patients living in or visiting an endemic area, a skin rash, and a positive 
serologic test for Borrelia burgdorferi. Oral doxycycline is the best treatment, and steroids may 
also resolve the inflammation.  
Herpes zoster is a rare cause of orbital myositis, but several cases have been extracted by a 
PubMed search (Badilla et al., 2007; Kawasaki & Borruat, 2003; Krasniaanski et al., 2004; 
Volpe et al., 1991). The signs and symptoms of orbital myositis associated with herpes zoster 
are similar to those of acute orbital myositis. The characteristic skin rash of herpes zoster 
may develop after the ocular adnexal inflammatory conditions (Kawasaki & Borruat, 2003). 
Herpes zoster can be unilateral and can affect more than one extraocular muscle. Acyclovir 
can improve the ocular manifestations, and cure the disease before progressing to the 
chronic clinical stage. 
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Orbital myositis following streptococcal pharyngitis is also a rare condition.  Several cases 
have been reported based on a Pub Med search (Alshaikh et al., 2008; Belanger et al., 2010; 
Culligan et al., 2005; Purcell et al., 1981). The highest incidence of this type of orbital 
myositis is in infants and young adults. In general, the orbital myositis occurs two to six 
weeks after the development of streptococcal pharyngitis. The pathogenesis may have an 
immunocomprise factor rather than streptococcal A. Imaging studies show unilateral with 
single or multiple extraocular muscular enlargements. The orbital myositis following 
streptococcal pharyngitis responds to oral corticosteroids, and can be cured without 
progressing to the chronic stage.  
3.2 Orbital myositis associated with autoimmunity 
Cases of orbital myositis associated with autoimmunity are associated with relatively 
specific autoimmune diseases; giant cell myocarditis, Crohn disease, systemic lupus 
erythematosus, rheumatoid arthritis, and linear scleroderma.     
Idiopathic giant-cell myocarditis is a rare and fatal disorder. Relatively young adults (mean 
age 43 years-old) are affected, and they usually die of heart failure and ventricular 
arrhythmia (Cooper et al., 1997). Nineteen percent of patients are associated with 
autoimmune disorders: Crohn disease, ulcerative colitis, and orbital myositis (Cooper et al., 
1997).  Five cases of orbital myositis associated with giant cell myocarditis have been 
published based on a Pub Med search (Kattah et al., 1990; Klein et al., 1989; Leib et al., 1994; 
Lind-Ayres et al., 2009; Stevens et al., 1996). The patients were 14-to 65-years-old and all 
were women. Their signs and symptoms are similar to those of patients with idiopathic 
orbital myositis, and patients present with periorbital pain, proptosis, ptosis, ocular motility 
restrictions, and swelling of the extraocular muscles including their tendons. Steroid 
treatments improve their signs and symptoms, but patients can develop cardiogenic 
episodes usually within a couple of months of onset of orbital myositis. Therefore, 
physicians should consider the possibility of idiopathic giant-cell myocarditis especially 
when a young woman is diagnosed with idiopathic orbital myositis.   
Inflammatory bowel diseases, e.g., Crohn disease and ulcerative colitis, have ocular 
manifestations in 4% to 12% of the cases (Ghanchi et al., 2003). The signs and symptoms 
include scleritis, uveitis, neuro-ophthalmic, corneal and retinal complications, and orbital 
pseudotumor. Orbital inflammation is believed to be a true complication of inflammatory 
bowel disease (Ghanchi et al., 2003). Orbital inflammation rapidly responds to systemic 
steroids but a reduction of the steroid dose may lead to recurrences. 
Scleroderma is a chronic autoimmune disease previously called the CREST syndrome and it 
has cutaneous manifestations that affect the arms and face. It is characterized by fibrosis, 
vascular alternations, and autoantibodies. The ocular manifestations involve the extraocular 
muscles which can appear atrophic (Suttorp-Schulten & Koornneef, 1990) or enlarged 
(Ramboer et al., 1997).  
Several cases of orbital myositis associated systemic lupus erythematosus (Grimson et al, 
1983; Serop et al., 1994) and rheumatoid arthritis have been published (Nabili et al., 2002; 
Panfilio et al., 2000).  
4. Differential diagnosis 
Orbital myositis is characterized by periocular and/or orbital inflammations and 
extraocular muscle enlargements. Various diseases must be differentiated from orbital 
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myositis. First, periocular and/or orbital inflammations of idiopathic orbital inflammation 
and orbital cellulitis are similar to those of orbital myositis. Second, signs and symptoms of 
thyroid-associated orbitopathy have also similar to those of orbital myositis and it has high 
incidence among the orbital diseases. Finally, primary and secondary carcinoma, 
lymphoproliferative lesions, parasite infection, anti-neutrophil cytoplasmic antibody-
mediated systemic vasculitis, some kind of drugs and foreign bodies can lead to extraocular 
muscle enlargements. 
4.1 Idiopathic orbital inflammation 
Idiopathic orbital inflammation is caused by unknown etiology, and inflammatory 
conditions are specific to the ocular adnexa: a lacrimal gland, an eye ball, extraocular 
muscles, and an optic nerve (Figure 8). This may be due to a number of different organ-
specific immunologic disorders of more specific etiologies yet to be defined (Rootman, 
2003). Imaging studies can differentiate each type. However, periocular type and idiopathic 
orbital myositis arising from superior or inferior extraocular muscles may often be difficult 
to differentiate between them. 
 
 
Fig. 8. CT images of each type of idiopathic orbital inflammation. A: orbital myositis, B: 
perioptic type, C: periocular type, D: apical type, E: lacrimal type, F: diffuse type 
4.2 Orbital cellulitis 
Orbital cellulitis is the inflammation caused by bacterial infections. It may be difficult to 
differentiate eye with orbital cellulitis from orbital myositis especially at early stage. 
Therefore, the diagnosis orbital myositis is often made following initial therapy for potential 
infectious etiology (Costa et al., 2009). In general, idiopathic orbital myositis characterizes a 
sudden onset. In addition, signs and symptoms reach their peak intensity at the initial onset. 
In contrast, orbital cellulitis characterizes an acute onset, but progressively develops signs 
and symptoms. Even though signs and symptoms resemble that of orbital myositis at active 
phase of orbital cellulitis (Figure 9), imaging studies may help a differential diagnosis 
between them. CT scans of idiopathic orbital myositis reveal extraocular muscle 
enlargements, whereas those of orbital cellulitis reveal fuzzy diffuse pattern in the orbit 
(Figure 9). However orbital cellulitis often progressive to massive lesions (Rootman, 2003). 
MR images of idiopathic orbital myositis reveal localized inflammations specific to affected 
extraocular muscles, whereas, those of orbital cellulitis reveal same signals in the vitreous 
body due to abscess formations that extend diffusely to the orbit (Figure 9). 
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Fig. 9. Orbital cellulitis. A 60-year-old woman with orbital cellulitis had right upper lid 
swelling, chemosis, and ptosis at active phase. CT image shows fuzzy diffuse pattern in the 
orbit (arrowhead) and a lack of mass lesions. Fat-suppressed T2-weighted MR image shows 
high intensity signals that extend diffusely to the orbit (arrow). Compare the image with 
those of orbital myositis (Figure 1 to 7).  
4.3 Thyroid-associated orbitopathy 
Thyroid-associated orbitopathy is the most specific disease that shows extraocular muscle 
enlargements. The differential diagnosis thyroid-associated orbitopathy and orbital myositis 
are shown in Table 2. Patients with thyroid-associated orbitopathy had typically lack pain, 
have eyelid retraction with lagophthalmos, thyroid associated autoantibodies, and sparing 
of the extraocular muscle tendons on imaging (Figure 10). However, the signs and 
symptoms may overlap those of orbital myositis. For example, idiopathic orbital myositis 
without tendon involvement has been reported (Patrinely et al., 1989). 
 
 Idiopathic orbital myositis 
Thyroid-associated 
orbitopathy 
Onset Sudden, acute Subacute, chronic 
Periocular inflammatory 
signs 
Frequent  Infrequent 
Bilaterality Infrequent  Frequent 
Eyelid Frequent ptosis Frequent lid retraction 
Extraocular movements 
Limitation in the field of action 
and often in the direction 
opposite to the field of action of 
the affected extraocular 
muscles 
Limitation in the direction 
opposite to the field of 
action of the affected 
extraocular 
CT image 
Indistinct swelling and frequent 
tendon involvement 
Distinct swelling and 
infrequent tendon 
involvement 
Fat-suppressed T2-
weighted MR image 
A hyperintense signal around 
fascicle structures in acute type 
or a hyperintense signal in the 
muscle in chronic type 
A hyperintense signal in 
the muscle 
Thyroid-associated 
autoantibodies 
Negative Frequently positive 
Response to steroids 
Dramatic with complete 
resolution in acute type and 
incomplete or recurrent in 
chronic type  
Incomplete and slow 
Table 2. Differential diagnosis of idiopathic orbital myositis versus thyroid-associated 
orbitopathy. 
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Fig. 10. Thyroid-associated orbitopathy. External photographs of a 44-year-old woman 
showing bilateral lid retraction, proptosis, and ocular motility restriction. CT image shows 
extraocular muscle enlargements without tendon involvement.   
4.4 Primary and metastatic tumors 
In a large cohort case series of orbital tumors and simulating lesions in the United States, 
Canada, and Japan, ocular adnexal lymphoid tumors accounted for approximately 10% to 
18% of all cases (Garrity et al., 2007; Rootman, 2003; Shields et al., 2004; Shikishima, et al., 
2006). Among malignant lymphomas, marginal zone B cell lymphomas made up the 
majority of the lymphomas arising from the ocular adnexa (Ferry et al., 2008). Among 
benign lymphoproliferative disorders, ocular adnexal IgG4-related related 
lymphoplasmacytic infiltrative disorder appeared to be a separate clinical entity that has 
unique clinical characteristics (Kubota et al., 2010). The signs and symptoms of them are 
frequently similar to those of atypical idiopathic orbital myositis (Figure 11 and 12). When 
patients have their sings and symptoms, physicians should consider either atypical 
idiopathic orbital myositis or ocular adnexal lymphoproliferative disorders. They should 
also consider an inicisional biopsy.   
In the cohort case series studies, secondary or metastatic tumors account for approximately 
20% to 40% of all cases (Garrity et al., 2007; Rootman, 2003; Shields et al., 2004; Shikishima, 
et al., 2006). Any malignant tumors in the body have a potential to metastasize to the 
extraocular muscles, and malignant tumor from the lung, breast, and thyroid ware found to 
predominate (Shikishima et al., 2006).  
In imaging studies, the extraocular muscles in eyes with idiopathic orbital myositis appear 
indistinct and enlarged. On the other hand, metastatic tumors to the extraocular muscle 
appear sharply defined with irregular extraocular muscle enlargement (Figure 13). 
However, the images also resemble those of eyes with orbital myositis (Capone & Slamovis, 
1990; Devine & Anderson, 1982; Slagle et al., 2009).   
 
 
Fig. 11. Primary marginal zone B-cell lymphoma arising from left lateral rectus muscle. A 
62-year-old man had periocular pain and ocular motility restrictions at initial visit.  After 
steroid pulse therapy, he recovered from ocular symptoms but conjunctival mass lesions 
and extraocular muscle enlargements remained. 
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Fig. 12. Secondary follicular lymphoma. CT image of the orbit of a 57-year-old man with a 
history of follicular lymphoma had extraocular enlargements. Note that ocular motility is 
within normal limits despite of extraocular enlargements. 
 
 
Fig. 13. Secondary carcinomas metastatic to extraocular muscles. Cases of breast carcinoma 
(left) and gastric carcinoma (Right) that metastasized to the orbit. Note that definitive and 
irregular enlargements of the extraocular muscle (arrowheads). 
4.5 Parasitic infections 
Two species of parasitic worms can infect the extraocular muscles; orbital sparganosis is 
reported mainly in eastern Asia and orbital cysticercosis mainly in India. Orbital 
sparganosis is caused by Spirometra erinaceieuropaei and can be acquired by drinking water 
containing copepods infected with the larval stage of the parasite. The orbit is a favorable 
site (Wiwanitkit, 2005; Yoon et al., 2004), and sparganosis can infect the extraocular muscles. 
(Figure 14; Kubota & Itoh, 2007).  It is difficult to distinguish orbital myositis associated with 
sparganosis from idiopathic orbital myositis. A presumptive diagnosis of sparganosis can be 
made by finding a painful migratory subcutaneous nodule (Markell et al., 1999). An accurate 
diagnosis is made following the surgical removal and identification of the worm.   
Orbital cysticercosis is caused by a parasitic Cysticerucus cellulosae infection which can infect 
the extraocular muscles. The host for C. cellulosae is the pig, and patients usually acquire the 
infection by eating undercooked pork. Imaging studies of orbital cysticercosis are 
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characteristic, and the findings can differentiate of orbital cysticercosis from idiopathic 
orbital myositis (Angotti-Neto et al., 2007; Pushker et al., 2002; Rath et al., 2010) 
 
 
Fig. 14. Orbital axial and coronal CT images of a case of sparganosis at initial visit. Left and 
middle: Left superior rectus muscle is swollen. The images suggest orbital myositis. Right: 
Glistening and whitish larva about 7 cm long. Reproduced with permission from Kubota, T. 
& Itoh, M. (2007) Sparganosis associated with orbital myositis. Japanese Journal of 
Ophthalmology, Vol.51, No. 4, pp.311-312, ISSN:0021-5155 
4.6 Anti-neutrophil cytoplasmic antibody (ANCA)-related vasculitis 
Patients with systemic ANCA-related vasculitis, e.g., Churg-Strauss syndrome and Wegener 
granulomatosis, often also have pseudotumors in the ocular adnexae. The pseudotumors 
may resemble orbital myositis (Figure 15; Fujii et al., 2010; Takanashi et al., 2001). The ocular 
symptoms are often intolerable periocular pain that is markedly reduced following 
prednisolone plus cyclophosphamide.   
 
 
Fig. 15. Churg-Strauss syndrome. A 68-year-old man with Churg-Strauss syndrome had 
periocular pain and restrictions of ocular motility. CT image shows an apparent lateral 
rectus enlargement. 
4.7 Orbital foreign body 
Some foreign bodies may cause orbital inflammation. Polymethyl methacrylate (PMMA) is 
used by cosmetic surgeons in some countries, and can occasionally lead to serious ocular 
complications including orbital myositis (Figure 16; Kubota & Hirose, 2005; Sato et al., 2007; 
Silva & Curi, 2004) 
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Fig. 16. Orbital inflammation associated with a foreign body. Left: A 29-year-old woman 
underwent cosmetic rhinoplastic surgery by a cosmetic surgeon. She developed ocular pain 
and a decrease of vision after the PMMA was injected. The right eye was displaced 
temporally leading to blepharoptosis. Her ocular motility was restricted. Right; T2-weighted 
MRI shows high signals from the right rectus muscles especially the medial rectus muscle. 
Reproduced with permission from Kubota T & Hirose H. (2005) Permanent loss of vision 
following cosmetic rhinoplastic surgery. Japanese Journal of Ophthalmology, Vol.49, No,6, 
pp.535-6, ISSN:0021-5155 
4.8 Orbital inflammation triggered by drugs 
Orbital inflammation including orbital myositis can be caused by bisphosphonates 
(Fraunfelder & Fraunfelder, 2003; Philips & Newman, 2008; Seth, et al., 2009; Sharma et al., 
2008; Subramanian et al., 2003) and also by influenza vaccine (Thurairajan et al., 1997).  
Physicians should aware of these rare orbital conditions. 
4.9 Arteriovenous shunting 
Carotid cavernous fistulas leads to diffuse symmetric enlargement of most of the extraocular 
muscles and an enlargement of the superior ophthalmic vein (Figure 17). 
 
 
Fig. 17. Carotid cavernous fistulas. External photographs of a 65-year-old woman with 
swelling of the right eyelid and conjunctival injection. CT and MRI images show 
enlargements of the right superior, inferior, and medial rectus muscles and superior oblique 
muscles. In addition, an enlargement of the superior ophthalmic vein can also be seen 
(arrow).  
4.10 Intramuscular hemangioma of the extraocular muscles. 
Intramuscular hemangioma of the extraocular muscles is a rare clinical entity. Patients with 
intramuscular hemangioma of the extraocular muscles have isolated enlargement of 
extraocular muscles without pain and ocular motility restrictions (Kiratli et al., 2003).  MR 
images show isointense T1-weight and hyperintense on T2-weight images, compared with 
extraocular muscles (Kiratli et al., 2003). 
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5. Treatments 
Idiopathic orbital myositis is characterized by a variable natural course of evolution with 
spontaneous remission (Kubota & Kano, 2007; Slavin et al., 1982) to a corticosteroids-
resistant progressive course. The first-line treatment is corticosteroids.  It is believed that 
delayed diagnosis and treatment may lead to permanent dysfunction and both prompt 
therapy and a slow prolonged steroid taper can prevent ocular motility restrictions and 
recurrences (Costa et al., 2009; Scott & Siatkowski, 1997). In corticosteroids-resistant cases, 
the second-line treatment is done in a stepwise manner: first radiation, second 
immunosuppressive, and third biological agents. 
5.1 Steroid treatment 
It has been reported that oral NSAIDs are effective for idiopathic orbital myositis in a case 
series study (Mannor et al., 1997). However, in general the first-line treatment is 
corticosteroids. In the literature review, different initial doses ranging from 20 to 120 mg a 
day of oral prednisolone and 1000 mg intravenous methylprednisolone for 3 days have been 
used, and idiopathic orbital myositis frequently shifts toward recurrent and chronic course 
up to 75% despite the corticosteroids treatments (Costa et al., 2009). 
5.2 Radiation therapy 
Radiation therapy ranging from 16 to 30 Gy has been used for orbital myositis in 
corticosteroids-resistant cases or has been used as a corticosteroid-sparing method.  In a 
review of radiation therapies patients with orbital myositis, approximately one-half of 
patients had a recurrence (Isobe et al., 2004). 
5.3 Immunosuppressive therapy   
Several case reports of immunosuppressive therapy for idiopathic orbital myositis have 
been published. Cyclosporine (Sanchez-Roman, et al. 1993), cyclophosphamide (Gunalp et 
al., 1996), and methotrexate (Kubota & Kano, 2007) have been use with variable results. 
5.4 Biological agents 
Therapy with tumor necrosis factor (TNF)-alpha inhibitor, such as infliximab is efficacious 
for immune-mediated inflammatory conditions, including rheumatoid arthritis and Crohn 
disease. Several published data showed that biological agents were successful in treating 
orbital myositis refractory to corticosteroids (Garrity et al., 2004; Miquel et al., 2008; Sahin et 
al., 2009) including orbital inflammatory disease (Kapadia & Rubin, 2006).  
6. Conclusions 
The etiology of orbital myositis is unknown. Orbital myositis associated with specific 
autoimmune disorders especially of giant cell myocarditis and Crohn disease may suggest a 
clue of pathogenesis of idiopathic orbital myositis, although the incidence of orbital myositis 
associated with autoimmune diseases is extremely low. Published case series studies have 
provided the best treatments by different initial doses of corticosteroids. But it appears to be 
difficult to evaluate the effectiveness for them using a meta-analysis. The acute and 
chronic/recurrent type of orbital myositis clearly respond differently to corticosteroids, 
therefore the type should be diagnosed before the treatment. Fat-suppressed T2-weighted 
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MR imaging may provide one of the predictive factors. Some orbital myositis refractory to 
corticosteroids can be effectively treated by immunosuppressive therapy and biologic 
agents. However, there is no randomized or comparison study and predictive factors for the 
effectiveness of different treatments.  
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